The Chemotype of Chromanones as a Privileged Scaffold for Multineurotarget Anti-Alzheimer Agents

被引：4

作者：

Keuler, Tim ^{[1
]}

Lemke, Carina ^{[1
,2
]}

Elsinghorst, Paul W. ^{[1
,2
]}

Iriepa, Isabel ^{[3
]}

Chioua, Mourad ^{[4
]}

Martinez-Grau, Maria Angeles ^{[5
]}

Beadle, Christopher D. ^{[6
]}

Vetman, Tatiana ^{[7
]}

Lopez-Munoz, Francisco ^{[8
]}

Wille, Timo ^{[9
]}

Bartz, Ulrike ^{[10
]}

Deuther-Conrad, Winnie ^{[11
]}

Marco-Contelles, Jose ^{[4
]}

Guetschow, Michael ^{[1
]}

机构：

[1] Univ Bonn, Pharmaceut Inst, Pharmaceut & Med Chem, D-53121 Bonn, Germany

[2] Cent Inst Bundeswehr, Med Serv Munich, D-85748 Garching, Germany

[3] Univ Alcala, Dept Quim Organ & Quim Inorgan, Madrid 28871, Spain

[4] CSIC, IQOG, Lab Med Chem, Madrid 28006, Spain

[5] Eli Lilly & Co, Lilly Res Labs, Madrid 28108, Spain

[6] Eli Lilly & Co, Lilly Res Ctr, Windlesham GU20 6PH, Surrey, England

[7] Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USA

[8] Camilo Jose Cela Univ Madrid UCJC, Fac Hlth, Neuropsychopharmacol Unit, Madrid 28692, Spain

[9] Bundeswehr Inst Pharmacol & Toxicol, D-80937 Munich, Germany

[10] Univ Appl Sci Bonn Rhein Sieg, Dept Nat Sci, D-53359 Rheinbach, Germany

[11] Inst Radiopharmaceut Canc Res, Helmholtz Zentrum Dresden Rossendorf, Dept Neuroradiopharmaceut, D-04318 Leipzig, Germany

来源：

ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE | 2022年 / 5卷 / 11期

关键词：

chromanones; Alzheimer?s disease; multineurotarget agents; 1 and ?2 receptors; monoamine oxidases; human cholinesterases; MONOAMINE-OXIDASE; PHARMACOLOGICAL EVALUATION; COGNITIVE DEFICITS; SIGMA(1) RECEPTOR; CRYSTAL-STRUCTURE; INHIBITORS; OPTIMIZATION; DERIVATIVES; LIGANDS; POTENT;

D O I：

10.1021/acsptsci.2c00097

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

The multifactorial nature of Alzheimer's disease necessitates the development of agents able to interfere with different relevant targets. A series of 22 tailored chromanones was conceptualized, synthesized, and subjected to biological evaluation. We identified one representative bearing a linker-connected azepane moiety (compound 19) with balanced pharmacological properties. Compound 19 exhibited inhibitory activities against human acetyl-, butyrylcholinesterase and monoamine oxidase-B, as well as high affinity to both the sigma 1 and sigma 2 receptors. Our study provides a framework for the development of further chromanone-based

引用

页码：1097 / 1108

页数：12

共 50 条

[1] Molecular scaffold and biological activities of anti-Alzheimer agents
Alanazi, Fars K.
Radwan, Awwad A.
Aou-Auda, Hisham
TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH, 2022, 21 (02) : 439 - 451
[2] Curcuminoids and resveratrol as anti-Alzheimer agents
Villaflores, Oliver B.
Chen, Ying-Ju
Chen, Chih-Ping
Yeh, Jui-Ming
Wu, Tzong-Yuan
TAIWANESE JOURNAL OF OBSTETRICS & GYNECOLOGY, 2012, 51 (04): : 515 - 525
[3] Chromenone: An emerging scaffold in anti-Alzheimer drug discovery
Agarwal, Uma
Verma, Saroj
Tonk, Rajiv K.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2024, 111
[4] Charge Density Studies on Anti-Alzheimer Agents
Luger, P.
Mebs, S.
Weber, M.
Dittrich, B.
ACTA CRYSTALLOGRAPHICA A-FOUNDATION AND ADVANCES, 2014, 70 : C969 - C969
[5] Natural Products as Potential Anti-Alzheimer Agents
Panda, Siva S.
Jhanji, Nancy
CURRENT MEDICINAL CHEMISTRY, 2020, 27 (35) : 5887 - 5917
[6] Progress and Development of Carbazole Scaffold Based as Potential Anti-Alzheimer Agents Using MTDL Approach
Kumar, Nitin
Gupta, Pankaj
Bansal, Sahil
LETTERS IN DRUG DESIGN & DISCOVERY, 2022, 19 (12) : 1049 - 1067
[7] Indole: A privileged scaffold for the design of anti-cancer agents
Wan, Yichao
Li, Yuanhua
Yan, Chunxing
Yan, Mi
Tang, Zilong
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2019, 183
[8] Naturally occurring multipotent anti-Alzheimer's agents
Zhang, Hong-Yu
Yang, Da-Peng
Ji, Hong-Fang
EXPERT OPINION ON DRUG DISCOVERY, 2006, 1 (03) : 269 - 277
[9] Thiazolidinedione: A Privileged Scaffold for the Development of Anti-cancer Agents
Sun, Juan
Chen, Yue-Hu
Liu, Han-Yu
Hondo, Emmerson
Zhou, Yang
Wu, Yuan-Feng
CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2021, 21 (28) : 2529 - 2545
[10] Bivalent β-Carbolines as Potential Multitarget Anti-Alzheimer Agents
Rook, Yvonne
Schmidtke, Kai-Uwe
Gaube, Friedemann
Schepmann, Dirk
Wuensch, Bernhard
Heilmann, Joerg
Lehmann, Jochen
Winckler, Thomas
JOURNAL OF MEDICINAL CHEMISTRY, 2010, 53 (09) : 3611 - 3617

← 1 2 3 4 5 →